When the UCI announced they were to work with the AFLD at this year’s Tour de France, a ripple of quiet applause went through cycling’s echelons. Yet despite this step and the implementation of the most sophisticated testing ever seen in the Tour, it is possible that micro-dosing of EPO could go undetected by the biological passport. Anne Gripper, head of the UCI’s anti-doping programme was at the Tour until Sunday, collaborating with the AFLD in order to make sure that the competition …

Read more here:
UCI, AFLD running targeted testing at Tour
